AXAHY vs CB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: AXAHY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AXAHY and CB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AXAHY and CB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

AXA SA is a French multinational insurance group headquartered in Paris and led by CEO Thomas Buberl. It writes property and casualty (P&C) insurance for individuals and businesses, health and protection cover, and savings and life products, across France, the rest of Europe (notably Germany, Switzerland, Belgium, Italy, Spain and the UK and Ireland), Asia, and a set of international markets in Africa and Latin America. Through AXA XL it also runs one of the larger global specialty commercial and reinsurance platforms, writing complex risks such as marine, aviation, energy, cyber, and large property programs. In 2025 the group reported gross written premiums and other revenues of about EUR 116 billion (roughly $130 billion), up about 6%, and underlying earnings of about EUR 8.4 billion. AXA has spent the last several years simplifying itself: it sold its asset manager, AXA Investment Managers, to BNP Paribas for about EUR 5.1 billion in July 2025, keeping control over asset allocation through a long-term partnership, and it bought a 51% stake in Prima, the Italian digital motor insurer, in late 2025.

Full AXAHY guide

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. It underwrites commercial and personal P&C insurance, accident and health coverage, reinsurance, and life insurance across roughly 54 countries, serving multinational corporations, businesses, and individuals. Its scale and worldwide network let it service large multinational accounts that smaller carriers cannot, which creates a competitive barrier. The company is widely regarded for underwriting discipline, meaning it prioritizes writing profitable policies over chasing premium volume.

Full CB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AXAHY drivers: Growing Forward 2029 and EPS compounding; Capital return: dividends plus buybacks.
• CB drivers: Underwriting discipline and margins; Rising investment income.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Natural catastrophes are the most visible risk: European floods, hailstorms, windstorms and large US property losses can swing the P&C combined ratio and quarterly earnings, and climate change is making these events more frequent. For CB, as a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AXAHY if you believe its drivers more; CB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AXAHY and CB guides.

AXAHY. AXA trades at a modest multiple of earnings typical of large European composite insurers, with much of the expected shareholder return coming through a dividend yield in the mid 5% range plus a few points of buybacks rather than through multiple expansion. Management guided 2026 underlying EPS growth to the upper end of its 6% to 8% range and the 2027 to 2029 plan steps that up to 7% to 9%, so the valuation implicitly assumes the group keeps delivering on targets. Figures are reported in euros; dollar figures are approximations at roughly 1.15 to 1.17 USD per EUR, and the ADR price and market capitalisation move with both the Paris share price and the exchange rate.

CB. As of October 16, 2026, Chubb trades near $356, about 12.6 times trailing earnings and 1.8 times book value, broadly in line with large P&C peers even after a 33% one-year gain. Second-quarter 2026 EPS of $7.26 beat consensus by about $0.51. Third-quarter results arrive October 20, 2026, where consensus expects EPS of about $6.80 on roughly $13.5 billion of revenue.

Headline figures (approximate, October 2026): AXAHY shows gross written premiums and other revenues (fy2025) ~EUR 116B (~$130B), +6%, underlying earnings (fy2025) ~EUR 8.4B; underlying EPS ~EUR 3.86 (+8%), underlying eps (1h 2026) ~EUR 2.19 (+8% vs 1H 2025), solvency ii ratio ~224% (Dec 31, 2025); ~215% pro forma Jan 1, 2026; CB shows revenue (ttm) ~$61.9 billion, revenue growth (q2 2026) ~6% year over year, net income (ttm) ~$11.2 billion (~18% profit margin), eps ~$28.23 trailing, ~$29.26 forward.

AXAHY and CB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AXAHY and CB exposure against your real portfolio. It is not an investment adviser.